Lin Patrick 4/A
4/A · Processa Pharmaceuticals, Inc. · Filed Feb 18, 2025
Insider Transaction Report
Form 4/AAmended
Lin Patrick
Chief Business - Strategy Off
Transactions
- Award
Warrants
2025-01-29+43,500→ 43,500 total(indirect: By Trust)Exercise: $0.65From: 2025-01-29Exp: 2030-01-29→ Common Stock (43,500 underlying) - Award
Warrants
2025-01-29+21,750→ 21,750 total(indirect: By Trust)Exercise: $0.65From: 2025-01-29Exp: 2030-01-29→ Common Stock (21,750 underlying)
Holdings
- 29,059
Common Stock
- 43,500(indirect: By Trust)
Common Stock